← All organizations
Highest phase reached
Phase 2
First clinical trial
Oct 1, 2016Last known activity
Jan 31, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (6 distinct, 5 trials)
Phase 2 (5 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Recent trials (8)
- NCT06177431CollaboratorPhase 1Jan 31, 2024
- NCT06177431Overall official - principal investigatorPhase 1Jan 31, 2024
- NCT05959850OfficialPhase 2Jun 13, 2023
- NCT05959850Overall official - principal investigatorPhase 2Jun 13, 2023
- NCT05509153Overall official - principal investigatorPhase 2Nov 1, 2022
- NCT04894240Overall official - principal investigatorPhase 1Dec 1, 2021
- NCT04894240CollaboratorPhase 1Dec 1, 2021
- NCT02868580CollaboratorPhase 1/Phase 2Oct 1, 2016
Details
- Last known activity
- Jan 31, 2024